
Tyme Technologies TYME
Quarterly report 2022-Q2
added 08-09-2022
Tyme Technologies EBITDA per Share 2011-2026 | TYME
Annual EBITDA per Share Tyme Technologies
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.203 | -0.225 | -0.286 | -0.214 | -0.18 | - | -0.11 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.11 | -0.286 | -0.203 |
Quarterly EBITDA per Share Tyme Technologies
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | -0.04 | - | -0.03 | -0.11 | -0.04 | - | -0.05 | -0.05 | -0.06 | -0.06 | -0.06 | -0.06 | -0.06 | -0.06 | -0.08 | -0.08 | -0.07 | -0.06 | -0.06 | -0.06 | -0.04 | -0.04 | -0.04 | -0.04 | -0.04 | -0.07 | -0.03 | -0.03 | -0.03 | -0.02 | - | -0.01 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -0.01 | -0.11 | -0.051 |
EBITDA per Share of other stocks in the Biotechnology industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-15.2 | - | 2.43 % | $ 254 M | ||
|
BioNTech SE
BNTX
|
62.6 | $ 97.54 | 2.14 % | $ 27.2 B | ||
|
Aligos Therapeutics
ALGS
|
-8.81 | $ 8.65 | 8.19 % | $ 85.5 M | ||
|
Alterity Therapeutics Limited
ATHE
|
-1.68 | $ 3.63 | -2.42 % | $ 8.73 B | ||
|
I-Mab
IMAB
|
0.08 | - | - | $ 866 M | ||
|
AlloVir
ALVR
|
-3.02 | - | 4.14 % | $ 49.1 M | ||
|
Applied Molecular Transport
AMTI
|
-3.2 | - | - | $ 10.1 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
6.75 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
-2.24 | - | 2.54 % | $ 160 B | ||
|
Biophytis SA
BPTS
|
-0.23 | - | -13.47 % | $ 169 M | ||
|
Applied Therapeutics
APLT
|
-0.77 | - | - | $ 8.42 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.22 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
-0.09 | - | -18.52 % | $ 27.3 M | ||
|
Esperion Therapeutics
ESPR
|
0.29 | $ 2.14 | -1.38 % | $ 445 M | ||
|
Evogene Ltd.
EVGN
|
-0.77 | $ 0.81 | -0.07 % | $ 27.9 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
3.68 | $ 20.47 | 0.49 % | $ 957 M | ||
|
Genmab A/S
GMAB
|
10.4 | $ 28.2 | -0.18 % | $ 18 B | ||
|
Grifols, S.A.
GRFS
|
0.87 | $ 8.19 | -0.24 % | $ 6.83 B | ||
|
GT Biopharma
GTBP
|
-2.25 | $ 0.36 | -2.82 % | $ 1.98 M | ||
|
Acorda Therapeutics
ACOR
|
-188 | - | -24.86 % | $ 820 K | ||
|
Институт стволовых клеток человека
ISKJ
|
-2.69 | - | - | - | ||
|
Halozyme Therapeutics
HALO
|
4.01 | $ 67.06 | -1.12 % | $ 8.04 B | ||
|
Adverum Biotechnologies
ADVM
|
-6.85 | - | - | $ 86.2 M | ||
|
Advaxis
ADXS
|
-5.96 | - | -9.65 % | $ 45.9 M | ||
|
Aeterna Zentaris
AEZS
|
-0.08 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
-2.35 | - | -10.17 % | $ 12.2 K | ||
|
Harmony Biosciences Holdings
HRMY
|
4.04 | $ 28.69 | -0.69 % | $ 1.65 B | ||
|
Aeglea BioTherapeutics
AGLE
|
-6.7 | - | - | $ 1.01 B | ||
|
Akebia Therapeutics
AKBA
|
0.1 | $ 1.41 | 0.71 % | $ 363 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-0.36 | - | - | $ 26.5 M | ||
|
Allakos
ALLK
|
-2.19 | - | - | $ 28.6 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-6.03 | $ 2.96 | 1.37 % | $ 4.87 M | ||
|
Aptinyx
APTX
|
-0.92 | - | -39.0 % | $ 4.57 M | ||
|
Aquestive Therapeutics
AQST
|
-0.66 | $ 4.16 | 1.84 % | $ 445 M | ||
|
Aravive
ARAV
|
-1.92 | - | -13.39 % | $ 1.45 M | ||
|
Arcutis Biotherapeutics
ARQT
|
-0.09 | $ 24.01 | -0.85 % | $ 3.05 B | ||
|
ImmuCell Corporation
ICCC
|
0.49 | $ 7.12 | 1.14 % | $ 64.3 M | ||
|
AIkido Pharma
AIKI
|
-3.89 | - | 1.93 % | $ 17.4 M | ||
|
Celldex Therapeutics
CLDX
|
-4.28 | $ 32.24 | - | $ 2.14 B | ||
|
Autolus Therapeutics plc
AUTL
|
-0.99 | $ 1.48 | -0.67 % | $ 394 M | ||
|
Aptose Biosciences
APTO
|
0.01 | - | -45.71 % | $ 1.2 M | ||
|
Immatics N.V.
IMTX
|
-1.37 | $ 10.48 | 0.43 % | $ 659 M | ||
|
Cidara Therapeutics
CDTX
|
-27.7 | - | - | $ 1.41 B | ||
|
Incyte Corporation
INCY
|
8.24 | $ 94.86 | -1.26 % | $ 18.5 B | ||
|
AVROBIO
AVRO
|
0.24 | - | 1083.1 % | $ 745 M | ||
|
Ayala Pharmaceuticals
AYLA
|
-2.42 | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
-0.39 | $ 2.61 | 2.35 % | $ 16.4 M | ||
|
InflaRx N.V.
IFRX
|
-1.49 | $ 1.05 | 4.5 % | $ 152 M | ||
|
AstraZeneca PLC
AZN
|
0.74 | - | - | $ 96.9 B | ||
|
Inventiva S.A.
IVA
|
-1.33 | $ 5.18 | -1.52 % | $ 138 M |